DIANA JIMENEZ: Open Payments
NPI 1215509336 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 25 payments from 14 companies in 2025. Trend: 2023 $1,441 · 2024 $2,785 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $141 |
| Organon LLC | 5 | $116 |
| ABBVIE INC. | 2 | $112 |
| Galderma Laboratories, L.P. | 1 | $33 |
| LEO Pharma Inc. | 2 | $33 |
| Amgen Inc. | 2 | $30 |
| KYOWA KIRIN, INC. | 1 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $26 |
| Incyte Corporation | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
Products named: DUPIXENT, RINVOQ, VTAMA, HADLIMA, NEMLUVIO, OTEZLA, Zoryve, OPZELURA.
Industry payments across AZ — which companies pay providers there.
